In this multidisciplinary roundtable discussion, moderator Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, the Medical Director of Sleep Medicine at Atrium Health, and Seema Khosla, MD, the Medical Director of the North Dakota Center for Sleep about the management of patients with insomnia, including the definition, prevalence, considerations for patients and clinicians, and preparing for sleep.
In this multidisciplinary roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, and Seema Khosla, MD, about the management of patients with obstructive sleep apnea and insomnia,...
In this multidisciplinary roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, and Seema Khosla, MD, about interventions for patients with insomnia, including cognitive...
Researchers systematically reviewed 21 studies with more than 400,000 participants to determine any associations between dry eye disease and sleep quality.
A 32-year-old first-time mother and her 3-month-old daughter come in for a well visit. At the visit, she asks whether it is okay to allow her daughter to sleep in her car seat, and if she can remove the car...
In this multidisciplinary roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, and Seema Khosla, MD, about the management of patients with obstructive sleep apnea and insomnia,...
In this multidisciplinary roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, and Seema Khosla, MD, about interventions for patients with insomnia, including cognitive...
In this multidisciplinary roundtable discussion, Jaspal Singh, MD, MHA, MHS, interviews Douglas Kirsch, MD, and Seema Khosla, MD, about the management of patients with insomnia, including the definition,...
In this podcast, Henriette Edemann-Callesen, MsC, PhD, discusses the safety of melatonin use in children and adolescents with chronic insomnia, including both short-term and long-term serious and...
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
